To evaluate the efficacy of pregabalin as adjunctive therapy, using a flexible, optimized
dose schedule with dose adjustment based on clinical response and tolerability, compared to
placebo in subjects with partial seizures
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.